CJC-1295 with DAC 5mg

Aprašymas

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide classified as a GHRH analog, studied in scientific and laboratory research. In scientific literature, it is described as being analyzed in models of endocrine signaling and hormonal regulatory mechanisms.

The DAC (Drug Affinity Complex) modification is studied as a structural feature related to compound stability and kinetic analysis in laboratory systems.

Scientific research context

In research models, it is analyzed in:

• regulation of growth hormone secretion in laboratory models;
• studies of IGF-1 axis signaling mechanisms;
• analysis of long-term hormonal response in experimental systems;
• modeling of pituitary signaling pathways;
• laboratory studies of pharmacokinetic properties of GHRH analogs.

All information is provided strictly within a scientific and preclinical context.

Product specification

• Form: lyophilized powder
• Appearance: white or off-white powder
• Quantity: 5 mg
• Purity: ≥98% (HPLC)
• Testing: independent laboratories

Substance identification

• Peptide name: CJC-1295 with DAC
• Classification: GHRH analog
• Modification: Drug Affinity Complex (DAC)
• Type: research peptide

Storage conditions

• Store in original, tightly closed packaging
• Keep in a dry, dark place
• Recommended temperature: 2–8 °C
• Short-term storage possible at 15–25 °C
• Avoid moisture and UV exposure
• Keep out of reach of children

Important information

• The product is not a medicinal product
• The product is not a dietary supplement
• The product is not a food product
• Not intended for human or animal consumption
• For scientific, laboratory, and analytical research purposes only

Supplied by BIOptide in collaboration with BioWell Labs, ensuring high purity and quality control. BIOptide assumes no responsibility for use outside the intended purpose.